These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 8178550)

  • 1. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.
    Alonso MJ; Gupta RK; Min C; Siber GR; Langer R
    Vaccine; 1994 Mar; 12(4):299-306. PubMed ID: 8178550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of release rate of tetanus vaccine from polyester microspheres.
    Alonso MJ; Cohen S; Park TG; Gupta RK; Siber GR; Langer R
    Pharm Res; 1993 Jul; 10(7):945-53. PubMed ID: 8378256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers.
    Gupta RK; Alroy J; Alonso MJ; Langer R; Siber GR
    Vaccine; 1997 Nov; 15(16):1716-23. PubMed ID: 9364673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of protein loading in biodegradable polymer microspheres containing tetanus toxoid.
    Gupta RK; Chang AC; Griffin P; Rivera R; Guo YY; Siber GR
    Vaccine; 1997; 15(6-7):672-8. PubMed ID: 9178469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel system based on a poloxamer/PLGA blend as a tetanus toxoid delivery vehicle.
    Tobío M; Nolley J; Guo Y; McIver J; Alonso MJ
    Pharm Res; 1999 May; 16(5):682-8. PubMed ID: 10350011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetanus toxoid microspheres consisting of biodegradable poly(lactide-co-glycolide)- and ABA-triblock-copolymers: immune response in mice.
    Jung T; Koneberg R; Hungerer KD; Kissel T
    Int J Pharm; 2002 Mar; 234(1-2):75-90. PubMed ID: 11839439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives.
    Johansen P; Men Y; Audran R; Corradin G; Merkle HP; Gander B
    Pharm Res; 1998 Jul; 15(7):1103-10. PubMed ID: 9688067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C; Doelker E
    J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres with entrapped pneumotropic bacterial antigens.
    Kofler N; Ruedl C; Klima J; Recheis H; Böck G; Wick G; Wolf H
    J Immunol Methods; 1996 Jun; 192(1-2):25-35. PubMed ID: 8699019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
    Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
    Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro degradation and dissolution behaviours of microspheres prepared by three low molecular weight polyesters.
    Lin SY; Chen KS; Teng HH; Li MJ
    J Microencapsul; 2000; 17(5):577-86. PubMed ID: 11038117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of in vitro and in vivo methods to study stability of PLGA microencapsulated tetanus toxoid vaccines.
    Sasiak AB; Bolgiano B; Crane DT; Hockley DJ; Corbel MJ; Sesardic D
    Vaccine; 2000 Nov; 19(7-8):694-705. PubMed ID: 11115690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved immunogenicity of a core-coated tetanus toxoid delivery system.
    Tobío M; Schwendeman SP; Guo Y; McIver J; Langer R; Alonso MJ
    Vaccine; 1999 Nov; 18(7-8):618-22. PubMed ID: 10547420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diphtheria and tetanus toxoid microencapsulation into conventional and end-group alkylated PLA/PLGAs.
    Johansen P; Tamber H; Merkle HP; Gander B
    Eur J Pharm Biopharm; 1999 May; 47(3):193-201. PubMed ID: 10382103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants.
    Raghuvanshi RS; Katare YK; Lalwani K; Ali MM; Singh O; Panda AK
    Int J Pharm; 2002 Oct; 245(1-2):109-21. PubMed ID: 12270248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers: Part III. Drug delivery application.
    Wu XS
    Artif Cells Blood Substit Immobil Biotechnol; 2004; 32(4):575-91. PubMed ID: 15974184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of tetanus toxoid from adjuvants and PLGA microspheres: how experimental set-up and surface adsorption fool the pattern.
    Johansen P; Corradin G; Merkle HP; Gander B
    J Control Release; 1998 Dec; 56(1-3):209-17. PubMed ID: 9801444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres.
    Sánchez A; Villamayor B; Guo Y; McIver J; Alonso MJ
    Int J Pharm; 1999 Aug; 185(2):255-66. PubMed ID: 10460920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of multi-phase microspheres of poly(D,L-lactic acid) and poly(D,L-lactic-co-glycolic acid) containing a W/O emulsion by a multiple emulsion solvent evaporation technique.
    Iwata M; McGinity JW
    J Microencapsul; 1992; 9(2):201-14. PubMed ID: 1593404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid).
    Frauke Pistel K; Breitenbach A; Zange-Volland R; Kissel T
    J Control Release; 2001 May; 73(1):7-20. PubMed ID: 11337055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.